APOE and type 2 diabetes mellitus: This implies that diabetic-related therapy may be helpful in counteracting the effects of apoE4 in AD and that anti-apoE4-related therapies [72,100] may be beneficial in blocking the neuropathological effects of T2DM in apoE4 carriers.